GEL Relative Valuation
GEL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GEL is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for GEL's competitors is 0.85, providing a benchmark for relative valuation. Genesis Energy LP Corp (GEL) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -6.27%, this premium appears unsustainable.
People Also Watch
WLFC
Willis Lease Finance Corp
138.060
USD
-0.15%
PRAX
Praxis Precision Medicines Inc
37.350
USD
+0.89%
BLBD
Blue Bird Corp
41.250
USD
+1.05%
GRDN
Guardian Pharmacy Services Inc
26.520
USD
+7.41%
BHLB
Berkshire Hills Bancorp Inc
26.360
USD
-0.64%
MRTN
Marten Transport Ltd
13.630
USD
-0.94%
ELME
Elme Communities
16.180
USD
-0.31%
EOSE
Eos Energy Enterprises Inc
6.510
USD
-6.73%
BUSE
First Busey Corp
22.540
USD
+0.27%
PBI
Pitney Bowes Inc
9.250
USD
-2.01%
FAQ
Is Genesis Energy LP (GEL) currently overvalued or undervalued?
Genesis Energy LP (GEL) is now in the Overvalued zone, suggesting that its current forward PS ratio of 0.75 is considered Overvalued compared with the five-year average of 0.39. The fair price of Genesis Energy LP (GEL) is between 6.29 to 14.47 according to relative valuation methord. Compared to the current price of 15.18 USD , Genesis Energy LP is Overvalued By 4.92% .
What is Genesis Energy LP (GEL) fair value?
How does GEL's valuation metrics compare to the industry average?
What is the current P/B ratio for Genesis Energy LP (GEL) as of May 20 2025?
What is the current FCF Yield for Genesis Energy LP (GEL) as of May 20 2025?
What is the current Forward P/E ratio for Genesis Energy LP (GEL) as of May 20 2025?